Johan Lars Isaksson

Johan Lars Isaksson is a Researcher at Uppsala University's Department of Immunology, Genetics and Pathology, working within the Cancer Precision Medicine research program under the Johan Botling Research Group. He maintains dual affiliations as both a researcher and doctoral student at the Center for Clinical Research in Gävleborg. His work bridges clinical research at Gävle Hospital with molecular oncology research at Uppsala University, focusing on lung cancer diagnostics, treatment, and molecular epidemiology.

Dr. Isaksson's research centers on lung cancer, particularly non-small cell lung cancer (NSCLC). His work spans molecular epidemiology, cancer biomarkers, precision medicine approaches, and the tumor microenvironment. He investigates predictive factors for treatment response, survival patterns, and disparities in cancer care across different patient populations. His research integrates population-based registry data with molecular analyses to develop more effective, personalized treatment strategies for lung cancer patients.

Analysis of Dr. Isaksson's recent publications reveals a strong focus on translational lung cancer research. His work examines biomarkers for immunotherapy response, molecular subtypes of NSCLC, and the impact of specific mutations (particularly KRAS) on treatment outcomes. He also investigates healthcare disparities related to age, immigration status, and adherence to clinical guidelines. His research increasingly incorporates spatial analysis of the tumor microenvironment and liquid biopsy approaches for minimally invasive monitoring.

Dr. Isaksson has made significant contributions to the field through numerous peer-reviewed publications in high-impact oncology journals including Journal of Thoracic Oncology, Lung Cancer, and European Journal of Cancer. His work often involves large population-based studies utilizing the National Swedish Lung Cancer Registry, providing valuable insights into real-world cancer care and outcomes.